This program project grant is focused on understanding the physiological and biochemical alterations in the brain underlying changes in cognition during aging and Alzheimer's disease. There are several themes that weave throughout the program project. The first theme is to examine the role of oxidative stress in aging. Projects 13, 15, 4 and 16 will continue their collaboration regarding nutritional interventions with diets high in antioxidants. Thus we will extend our studies of interventions with antioxidants to LTP and also possible synergy with neurotrophins. A new theme for the renewal that threads through our program is the investigation of inflammatory processes in aging and its relation to oxidative stress. Project 13 and Project 4 have examined a line of rats resistant to oxidative stress that has an increased life span and does not show age-related declines in cerebellar physiology and motor learning, or age-related atrophy of basal forebrain cholinergic neurons. These rats have a deficiency in a microglial cell adhesion molecule (LFA-l), indicating reduced inflammation in aging, and a reduction in reactive oxygen species (ROS). The role of inflammation will be studied from a therapeutic angle in Project 14 looking at NSAIDS and specific COX-2 inhibitors. A third theme is related to biological substrates of age-related changes in cellular models for learning and memory, such as long-term potentiation (LTP). Projects 15 and 4 will examine trophic factor interactions with LTP, using intraocular transplants of hippocampus at different ages and denervation and NGF treatment as paradigms for NGF release. Project 3 will investigate PKA-dependent synthesis of AMPA receptors, and the transcriptional regulation of AMPA receptors by trophic factors will be examined in Project 16. Project 13 will examine alterations in PKA with age that will relate to these projects as well. Another focus of our program is age-related alterations of the basal forebrain cholinergic system; nicotinic receptors are studied in Project 14 and neurotrophic support in Project 4. Our particular strength is the multidisciplinary approach in our different research groups, from the whole animal behavior to single cell recording, morphology, and biochemical assays of protein levels. The long-term goal of our program is to understand the basic biological mechanisms of aging and cognition that will lead to new therapies for Alzheimer's disease and other age-related cognitive diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG004418-22
Application #
6930436
Study Section
Special Emphasis Panel (ZAG1-ZIJ-9 (J1))
Program Officer
Wise, Bradley C
Project Start
1984-03-01
Project End
2006-08-31
Budget Start
2005-07-15
Budget End
2006-08-31
Support Year
22
Fiscal Year
2005
Total Cost
$1,074,074
Indirect Cost
Name
University of South Florida
Department
Neurosurgery
Type
Schools of Medicine
DUNS #
069687242
City
Tampa
State
FL
Country
United States
Zip Code
33612
Bickford, Paula C; Flowers, Antwoine; Grimmig, Bethany (2017) Aging leads to altered microglial function that reduces brain resiliency increasing vulnerability to neurodegenerative diseases. Exp Gerontol 94:4-8
Grimmig, Bethany; Kim, Seol-Hee; Nash, Kevin et al. (2017) Neuroprotective mechanisms of astaxanthin: a potential therapeutic role in preserving cognitive function in age and neurodegeneration. Geroscience 39:19-32
Tajiri, Naoki; Acosta, Sandra A; Shahaduzzaman, Md et al. (2014) Intravenous transplants of human adipose-derived stem cell protect the brain from traumatic brain injury-induced neurodegeneration and motor and cognitive impairments: cell graft biodistribution and soluble factors in young and aged rats. J Neurosci 34:313-26
Lee, Daniel C; Ruiz, Claudia R; Lebson, Lori et al. (2013) Aging enhances classical activation but mitigates alternative activation in the central nervous system. Neurobiol Aging 34:1610-20
Lee, D C; Rizer, J; Hunt, J B et al. (2013) Review: experimental manipulations of microglia in mouse models of Alzheimer's pathology: activation reduces amyloid but hastens tau pathology. Neuropathol Appl Neurobiol 39:69-85
Ross, Jaime M; Stewart, James B; Hagström, Erik et al. (2013) Germline mitochondrial DNA mutations aggravate ageing and can impair brain development. Nature 501:412-5
Shahaduzzaman, Md; Golden, Jason E; Green, Suzanne et al. (2013) A single administration of human umbilical cord blood T cells produces long-lasting effects in the aging hippocampus. Age (Dordr) 35:2071-87
Olson, Linus; Faulkner, Stuart; Lundströmer, Karin et al. (2013) Comparison of three hypothermic target temperatures for the treatment of hypoxic ischemia: mRNA level responses of eight genes in the piglet brain. Transl Stroke Res 4:248-57
Morganti, Josh M; Nash, Kevin R; Grimmig, Bethany A et al. (2012) The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease. J Neurosci 32:14592-601
Li, Qingyou; Lebson, Lori; Lee, Daniel C et al. (2012) Chronological age impacts immunotherapy and monocyte uptake independent of amyloid load. J Neuroimmune Pharmacol 7:202-14

Showing the most recent 10 out of 317 publications